Primary Site >> Colorectal Cancer
Gene >> NAMPT
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. PMID: 10601642 |
Ref: Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. PMID: 12209988 |
Ref: Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. PMID: 17392604 |
Ref: Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. PMID: 20331631 |
Ref: The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. PMID: 22190494 |
Ref: Visfatin induces stromal cell-derived factor-1 expression by beta1 integrin signaling in colorectal cancer cells. PMID: 23042611 Ref: Circulating levels of novel adipocytokines in patients with colorectal cancer. PMID: 23474107 Ref: Adipocytokine levels of colon cancer patients before and after treatment. PMID: 23822624 Ref: Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells. PMID: 23922874 Ref: Resistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line. PMID: 24551805 |
Ref: Association between chemotherapy and plasma adipokines in patients with colorectal cancer. PMID: 25149999 Ref: Changes in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment. PMID: 25308845 Ref: Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells. PMID: 25486521 |
Ref: Nampt/PBEF/visfatin upregulation in colorectal tumors, mirrored in normal tissue and whole blood of colorectal cancer patients, is associated with metastasis, hypoxia, IL1beta, and anemia. PMID: 26075243 Ref: Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer. PMID: 26284136 Ref: Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro. PMID: 26348080 |
Ref: Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients. PMID: 23910020 Ref: Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism. PMID: 27058759 Ref: Visfatin level in patients with colorectal adenoma. PMID: 27390690 Ref: Role of omentin and chemerin in metabolic syndrome and tumor diseases. PMID: 27516571 |
Ref: Chemotherapy and plasma adipokines level in patients with colorectal cancer. PMID: 28402255 Ref: Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1). PMID: 28667355 |
Ref: NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP. PMID: 29203587 Ref: Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. PMID: 29662658 Ref: The role of metabolic syndrome variant in the malignant tumors progression. PMID: 29699953 Ref: Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer. PMID: 29761507 Ref: Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation. PMID: 29949049 Ref: Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer. PMID: 30191976 |